Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CLYM · against 478 other Healthcare companies of similar size
Ranked #13 of 479 · scores higher than 97% of peers · safety percentile 98
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)53 peers with a safety percentile of 90–100, including CLYM · Click a bar to see the companies
Mainly thanks to its current ratio, debt / equity and beta, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CLYM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 447 reported | 0.01× | 0.18× | 91% | 33% | |
| BetaLower is better · 458 reported | 0.10 | 0.40 | 83% | 33% | |
| Current ratioHigher is better · 474 reported | 31.45× | 2.86× | 99% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.1B USD | 100 | ||
| 2 | 1.0B USD | 99 | 35 | |
| 3 | 421M USD | 99 | 52 | |
| 4 | 397M USD | 99 | 37 | |
| 5 | 455M USD | 99 | 53 | |
| 9 | 15.6B TWD (≈$485M) | 98 | 49 | |
| 10 | 927M USD | 98 | 41 | |
| 11 | 14.9B TWD (≈$462M) | 98 | 42 | |
| 12 | 546M USD | 98 | 31 | |
| 13 | 560M USD | 98 | 42 | |
| 14 | 552M USD | 97 | 39 | |
| 15 | 675M USD | 97 | ||
| 16 | 371M USD | 97 | ||
| 17 | 293M USD | 97 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score